文献速递慢性肾脏病

肾功能与癌症风险的因果关联:孟德尔随机化研究

Causal Relationship Between Kidney Function and Cancer Risk: A Mendelian Randomization Study.
PubMed 文献 · Am J Kidney Dis · 2024-07-30

本研究采用两样本孟德尔随机化方法,利用CKDGen联盟的eGFR(n=567,460)和UACR(n=127,865)GWAS数据及UK Biobank的癌症结局(n=407,329),评估肾功能与总体癌症发病率、癌症死亡及部位特异性癌症的因果关联。结果显示,遗传预测的eGFR和UACR与总体癌症风险或癌症死亡均无显著关联,eGFR与总体癌症发病的OR为0.88(95%CI 0.40-1.97,P=0.8),UACR为0.90(95%CI 0.78-1.04,P=0.2)。结论提示未发现肾功能降低与癌症风险存在因果关系的证据。

要点

  • 遗传预测的eGFR和UACR与总体癌症风险及癌症死亡无显著因果关联。
  • eGFR与总体癌症发病的OR为0.88(95%CI 0.40-1.97,P=0.8),UACR为0.90(95%CI 0.78-1.04,P=0.2)。
  • 分层孟德尔随机化未发现eGFR与癌症存在因果关联的证据。

核心结论

  • 本研究未显示肾功能(eGFR和UACR)与总体癌症发病率及癌症相关死亡存在因果关联。

研究设计与样本

  • 两样本孟德尔随机化研究,使用CKDGen联盟eGFR(n=567,460)和UACR(n=127,865)的GWAS汇总数据及UK Biobank癌症结局(n=407,329)。

主要发现

  • 遗传预测的eGFR与总体癌症发病的OR为0.88(95%CI 0.40-1.97,P=0.8),UACR为0.90(95%CI 0.78-1.04,P=0.2),均无显著关联。
  • 遗传预测的肾功能与总体癌症风险或癌症死亡均无关联。
  • 针对eGFR与癌症的调整广义相加模型显示非线性证据,但分层孟德尔随机化未发现因果关联。

临床怎么用

  • 对于早期慢性肾脏病患者,遗传预测的肾功能降低未显示增加癌症风险的因果证据,提示临床观察到的癌症风险增加可能并非由肾功能降低直接导致。

局限性

  • 为避免样本重叠,使用了较小的UACR GWAS数据,可能削弱工具变量强度并引入群体分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Patients treated with kidney replacement therapy experience a 1.5- to 2-fold increased risk of cancer and cancer mortality compared with the general population. Whether this excess risk extends to people with earlier stage chronic kidney disease and whether reduced kidney function is causally related to cancer is unclear. STUDY DESIGN: Two-sample Mendelian randomization (MR). SETTING & PARTICIPANTS: Genome-wide association study (GWAS) summary statistics for estimated glomerular filtration rate (eGFR) (n=567,460) and urinary albumin-creatine ratio (UACR) (n=127,865) from the CKDGen consortium and cancer outcomes from the UK Biobank (n = 407,329). EXPOSURE: eGFR and UACR. OUTCOME: Overall cancer incidence, cancer-related mortality and site-specific colorectal, lung, and urinary tract cancer incidence. ANALYTICAL APPROACH: Univariable and multivariable MR conducted for all outcomes. RESULTS: The mean eGFR and median UACR were 91.4mL/min/1.73m2 and 9.32mg/g, respectively, in the CKDGen, and 90.4mL/min/1.73m2 and 9.29mg/g, respectively, in the UK Biobank. There were 98,093 cases of cancer, 15,850 cases of cancer-related death, 6,664 colorectal, 3584 lung, and 3,271 urinary tract cancer cases, respectively. The genetic instruments for eGFR and UACR comprised 34 and 38 variants, respectively. Genetically predicted kidney function (eGFR and UACR) was not associated with overall cancer risk or cancer death. The association between genetically predicted eGFR and UACR and overall cancer incidence had an odds ratio of 0.88 ([95% CI, 0.40-1.97], P=0.8) and 0.90 ([95% CI, 0.78-1.04], P=0.2) respectively, using the inverse-variance weighted method. An adjusted generalized additive model for eGFR and cancer demonstrated evidence of nonlinearity. However, there was no evidence of a causal association between eGFR and cancer in a stratified MR. LIMITATIONS: To avoid overlapping samples a smaller GWAS for UACR was used, which reduced the strength of the instrument and may introduce population stratification. CONCLUSIONS: Our study did not show a causal association between kidney function, overall cancer incidence, and cancer-related death. PLAIN-LANGUAGE SUMMARY: Does reduced kidney function cause cancer? Patients with chronic kidney disease have been shown to have an increased risk of cancer and cancer-related death. However, it is not clear whether kidney disease is causally related to cancer or the association is due to other factors such as immune suppression and inflammation or a result of distortion of the analyses from unidentified variables (confounding). We used large, published genetic studies as well a database including 407,329 people in the United Kingdom in a series of Mendelian randomization analysis. Mendelian randomization uses the random assignment of genetic variants at birth to investigate causal relationships without confounding from measured and unmeasured confounders. We found that there is no evidence of a causal relationship between reduced kidney function and cancer.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Dobrijevic E, van Zwieten A, Grant AJ, et al. Causal Relationship Between Kidney Function and Cancer Risk: A Mendelian Randomization Study. Am J Kidney Dis. 2024. PMID: 39084486. doi:10.1053/j.ajkd.2024.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。